VITRANO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 1.769
EU - Europa 603
AS - Asia 504
SA - Sud America 80
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.980
Nazione #
US - Stati Uniti d'America 1.755
SG - Singapore 183
RU - Federazione Russa 153
CN - Cina 127
IT - Italia 102
UA - Ucraina 67
DE - Germania 53
HK - Hong Kong 51
BR - Brasile 50
VN - Vietnam 50
FI - Finlandia 44
GB - Regno Unito 42
IE - Irlanda 37
PL - Polonia 32
JP - Giappone 23
FR - Francia 22
IN - India 18
KR - Corea 16
CA - Canada 10
BE - Belgio 9
CH - Svizzera 8
CI - Costa d'Avorio 8
SE - Svezia 8
BD - Bangladesh 7
CL - Cile 7
ES - Italia 7
RO - Romania 6
AR - Argentina 5
EC - Ecuador 5
AT - Austria 4
IQ - Iraq 4
NL - Olanda 4
PK - Pakistan 4
ZA - Sudafrica 4
CO - Colombia 3
MX - Messico 3
NG - Nigeria 3
NP - Nepal 3
PY - Paraguay 3
SN - Senegal 3
BO - Bolivia 2
KE - Kenya 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
TN - Tunisia 2
TR - Turchia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GR - Grecia 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
LI - Liechtenstein 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.980
Città #
Fairfield 287
Ashburn 245
Singapore 151
Woodbridge 123
Seattle 114
Houston 104
Chandler 95
Wilmington 87
Ann Arbor 69
Cambridge 68
San Jose 67
Hong Kong 50
Dublin 37
Jacksonville 35
Moscow 30
Beijing 29
Zgierz 28
Santa Clara 27
Medford 22
Tokyo 22
Council Bluffs 19
Dallas 17
Frankfurt am Main 17
Los Angeles 15
Altamura 14
Ho Chi Minh City 14
Palermo 14
Princeton 14
San Diego 14
Lauterbourg 13
Lawrence 13
São Paulo 12
Nanjing 11
Falls Church 10
Hanoi 10
New York 10
Springfield 10
Brussels 9
Buffalo 9
Dearborn 9
Des Moines 9
Abidjan 8
Chicago 8
Helsinki 8
Washington 8
Nuremberg 7
Tulsa 7
Cagliari 6
Changsha 6
Boardman 5
Brooklyn 5
Hebei 5
Jinan 5
London 5
Santiago 5
Cardiff 4
Chennai 4
Guayaquil 4
Jiaxing 4
Mumbai 4
Nanchang 4
Shenzhen 4
Stockholm 4
Vienna 4
Warsaw 4
Zurich 4
Dakar 3
Guangzhou 3
Johannesburg 3
Mazara Del Vallo 3
Montreal 3
Prineville 3
San Paolo di Civitate 3
Sandston 3
Seongnam 3
Shenyang 3
Valencia 3
Venice 3
Amsterdam 2
Auburn Hills 2
Bến Tre 2
Calgary 2
City of London 2
Da Nang 2
Denver 2
Fort Lauderdale 2
Haiphong 2
Hangzhou 2
Hefei 2
Hải Dương 2
Jeddah 2
Kuala Lumpur 2
La Paz 2
Ludhiana 2
Manchester 2
Milan 2
Montevideo 2
Oklahoma City 2
Palma Campania 2
Paris 2
Totale 2.165
Nome #
Nonsense-mediated decay mechanism is a possible modifying factor of clinical outcome in nonsense cd39 beta thalassemia genotype 408
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 246
Hematopoietic Stem Cell Mobilization for Gene Therapy: The Combination of G-CSF+Plerixafor in Patients with Beta-Thalassemia Major Provides High Yields of CD34+ Cells with Primitive Signatures 234
Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies 220
Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death 211
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients 211
Reliability of EMA Binding Test in Diagnosis of Hereditary Spherocytosis in Italian Patients 209
Modelling Spatio-Temporal Elephant Movement Data: a Generalized Additive Mixed Models Framework 197
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassemia major patients: a randomised clinical trial 188
Chelation treatment in sickle-cell-anaemia: much ado about nothing? 186
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in thalassemia major patients 186
The Challenge of Using CB-HSCs As Source for Gene Therapy: Lentiviral Vector Transduction, Phenotypic Characterization and Global Gene Expression Profile of Ex-Vivo Expanded CB CD34+ Cells 186
Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience 181
Iron Chelation Therapy in thalassaemia major: a sistematic review with meta-analyses of 1520 patients included on randomized clinical trials 166
Totale 3.029
Categoria #
all - tutte 9.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 20 25
2021/2022184 15 39 1 3 13 14 12 3 21 23 8 32
2022/2023248 22 54 2 19 28 39 7 20 39 4 6 8
2023/2024150 6 11 3 42 23 24 1 10 1 0 0 29
2024/2025221 2 21 19 22 7 19 16 21 9 23 28 34
2025/2026970 72 20 39 98 104 155 140 94 65 165 18 0
Totale 3.029